Weathering the storm together
It was a night to celebrate: MBI founder Fernando Goldsztein had the honor of stepping on stage together with MBI partner and medulloblastoma survivor Daniel Scola
A toast (of lemonade) to Ava and her friends
With the support of her family and dedicated friends, Ava Strong, an American girl with brain cancer, raised $225 with her lemonade stand…
MATCHPOINT: Has medulloblastoma met its match?
Duane Mitchell, MD, PhD, co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy at the University of Florida, is leading the MATCHPOINT trial. The treatment uses adoptive cell therapy…
Trials approved — and starting — in record time
Drs. Duane Mitchell and Elias Sayour of the Cure Group 4 Consortium have received approval from the U.S. Food and Drug Administration (FDA) to test…
You are invited to the Race for Every Child — Race for Every Child
It’s a real race in Washington DC, but you can enter from anywhere in the world — accelerating efforts to raise funds for research and care for children…
A milestone for MBI
Scientists, academics, researchers, businesspeople and media personalities met last Wednesday (10/04) at the Brazilian embassy in Washington…
To save a life: Lessons for Launching a Health R&D Initiative
In February 2024, MBI was featured in eJewish Philanthropy, a news publication covering the world of Jewish philanthropy. The platform features daily discussions through original reporting…
In search of treatment for medulloblastoma
In March 2024, PUCRS Magazine published a beautiful interview given by alumnus Fernando Goldsztein, Founder of The Medulloblastoma Initiative and Advisor to the Children’s National Hospital Foundation…
MBI at the largest scientific event on neuro-oncology in Latin America
Last Saturday (23), the founder of The Medulloblastoma Initiative (MBI), Fernando Goldsztein, participated in the Present-Future session of Snola 2024, the largest scientific neuro-oncology event in Latin America…
A big step for MBI
On Wednesday, March 6, the story of the Medulloblastoma Initiative (MBI) was presented to the Permanent Council of the OAS (Organization of American States), in Washington D.C., during the session dedicated to World Rare Disease Day…